Microbial cell envelope and membrane components

The microbial cell envelope and membrane components encompass the complex multi-layered structures that protect bacteria and fungi from environmental stress and maintain osmotic pressure. In bacteria, this includes the inner cytoplasmic membrane, the peptidoglycan cell wall, and, in Gram-negative organisms, an outer membrane containing lipopolysaccharides (LPS) [1][2]. Fungal cell envelopes are distinct, featuring a cell wall composed of chitin and glucans, and a cell membrane where ergosterol replaces cholesterol [3]. These components are vital for microbial viability and serve as primary targets for many antimicrobial classes due to their absence or structural difference in human cells [1]. For instance, beta-lactams and glycopeptides target peptidoglycan cross-linking, while polymyxins and daptomycin disrupt membrane integrity [2][4]. Antifungal agents like polyenes and azoles exploit the presence of ergosterol to selectively damage fungal membranes [3]. Because these structures are essential for survival, their disruption often leads to rapid microbial death or growth inhibition [1]. However, the broad nature of these targets means that drugs affecting them can also impact the host's beneficial microbiome [5].

Other names

Bacterial cell wallFungal cell wallCytoplasmic membraneOuter membranePeptidoglycan layerLipopolysaccharide layerErgosterol membrane

Antimicrobials targeting the cell envelope and membrane function through several distinct mechanisms: inhibition of cell wall biosynthesis (e.g., beta-lactams inhibiting penicillin-binding proteins), direct disruption of membrane integrity (e.g., polymyxins binding to LPS or daptomycin inserting into the cytoplasmic membrane), and inhibition of essential membrane components like ergosterol in fungi (e.g., azoles inhibiting lanosterol 14-alpha-demethylase) [1][2][3][4].